Key genes and pathways in tumor-educated dendritic cells by bioinformatical analysis

Area of Science:

• Immunology
• Cancer Biology
• Bioinformatics

Background:

• Tumor microenvironment (TME) signaling can hinder dendritic cell (DC) maturation, causing immune tolerance and unresponsiveness.
• This impaired DC function contributes to antigen-specific tolerance in lymphoid organs and peripheral tissues.

Purpose of the Study:

• To investigate the molecular mechanisms by which tumor microenvironment signaling affects dendritic cell function.
• To identify key genes and pathways involved in DC immune suppression within the tumor context.

Main Methods:

• Dendritic cells were stimulated with supernatants from LLC lung and 4T1 breast cancer cell lines.
• RNA sequencing was performed on stimulated and unstimulated DCs to identify differentially expressed genes.
• Bioinformatic analyses, including gene ontology, pathway enrichment, and protein-protein interaction network (PPI) analysis, were conducted.

Main Results:

• Tumor supernatants significantly altered DC surface molecule expression, upregulating inhibitory molecules (PD-L1/L2, VISTA) and downregulating co-stimulatory molecules (MHC-II, CD40, CD80).
• Messenger RNA levels of immunosuppressive cytokines (IL-6, IL-10) and arginase I were increased, while pro-inflammatory cytokines (TNF-α, IL-12a) were decreased.
• Bioinformatic analysis identified 405 differentially expressed genes enriched in immune response, cell-cell interactions, and hemostasis pathways. PPI analysis highlighted modules related to cell survival, adhesion, migration, and immune signaling.

Conclusions:

• Tumor-derived factors induce a tolerogenic phenotype in dendritic cells, characterized by altered gene expression and suppressed immune signaling.
• These findings elucidate the immune status of DCs within the tumor environment and highlight potential targets for cancer immunotherapy.